The TEVAR Center

Filter Your Results




Bolton Medical Begins Phase 2 Trial for RelayPro to Treat Descending TAA

May 16, 2017 -- Bolton Medical announced that the first patient has been enrolled in the RelayPro US Food and Drug Administration (FDA) phase 2 clinical trial, which is design…

Long-Term Data Show Durability of TEVAR in High-Risk Patients

May 9, 2017 -- Long-term data on the safety and durability of thoracic endovascular aortic repair (TEVAR) with the Zenith TX1 and TX2 devices (Cook Medical) were published by …

Study Evaluates EVAR Using Fenestrated-Branch Endografts Based on Supraceliac Sealing Zones

April 20, 2017 -- Gustavo S. Oderich, MD, et al conducted a prospective, nonrandomized study to evaluate manufactured fenestrated-branched endovascular aortic repair (EVA…

CE Mark Approval Data Published for Essential Medical's Manta Large-Bore Vascular Closure Device

April 3, 2017 -- Essential Medical, Inc. announced the publication of the CE Mark approval study of the Manta vascular closure device, "Percutaneous Plug-Based Arteriotom…

Thoracic Branch Endoprosthesis: Early Case Experience and the Clinical Trial

Michael D. Dake, MD; and Himanshu J. Patel, MD

March 2017—An evaluation of the device’s capabilities and early clinical experience.

Evolving Endovascular Treatment of Type B Dissection

With Martyn Knowles, MD; Mark Farber, MD; Robert S. Crawford, MD, FACS; and Bradley S. Taylor, MD, MPH

March 2017—Two leading centers weigh in on current practice.

Vascular Pioneer Edward B. Diethrich, MD, 1935–2017

February 28, 2017 -- Edward B. Diethrich, MD, a pioneer in noninvasive cardiovascular disease diagnosis and innovative surgical and minimally invasive treatments, succumbed to…

Terumo to Acquire Bolton Medical

January 19, 2017 -- Terumo Corporation announced a definitive agreement to acquire Bolton Medical, Inc. from its parent company. Bolton Medical develops, manufacture…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.